1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bms-470539

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bms-470539 in 1 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (bms-470539)	Trials (bms-470539)	Recent Studies (post-2010) (bms-470539)
9,156	187	552	13	0	10

Protein Interaction Comparison

Protein	Taxonomy	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)	bms-470539 (IC50)
Melanocyte-stimulating hormone receptor	Homo sapiens (human)		0.12

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carlson, K; Getting, S; Leoni, G; Nourshargh, S; Perretti, M; Voisin, MB	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bms-470539

Article	Year
The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. British journal of pharmacology, 2010, Volume: 160, Issue:1 Topics: Animals; Chemokine CCL2; Chemokine CXCL1; Chemotaxis, Leukocyte; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microvessels; Platelet Activating Factor; Receptor, Melanocortin, Type 1; Splanchnic Circulation; Vasculitis	2010

Article

Year

The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature.

British journal of pharmacology, 2010, Volume: 160, Issue:1

Topics: Animals; Chemokine CCL2; Chemokine CXCL1; Chemotaxis, Leukocyte; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microvessels; Platelet Activating Factor; Receptor, Melanocortin, Type 1; Splanchnic Circulation; Vasculitis

2010